Gaxos.ai Inc. is currently navigating a high-risk growth phase characterized by rapid revenue expansion from a nominal base, yet the company remains fundamentally challenged by a -140.8% operating margin as of 2026Q1. While the firm leverages a 100% gross marg...
Price trend, volume and key moving averages
Trailing total returns as of 9/24/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q3 2026Latest Aug 12, 2026 | $0.02+113.3% vs -$0.15 | $2M+36.7% vs $2M |
Q2 2026 May 14, 2026 | -$0.25-25.0% vs -$0.20 | $2M+0.0% vs $2M |
Q2 2026 Mar 17, 2026 | -$0.13+18.8% vs -$0.16 | $1M+20.4% vs $996,540 |
Q4 2025 Nov 13, 2025 | -$0.14 vs — | $498,271 vs — |
Exagen (NASDAQ: XGN - Get Free Report) and Gaxos.ai (NASDAQ: GXAI - Get Free Report) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, risk and dividends. Valuation and Earnings This table compares Exagen and Gaxos.ai"s
Roseland, NJ, Aug. 17, 2026 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. (NASDAQ: GXAI), (“Gaxos” or the “Company”), a company developing artificial intelligence applications across various high-growth sectors, today announced the closing of its previously announced exercise of certain outstanding warrants to purchase up to an aggregate of 3,007,654 shares of common stock originally issued in December 2024 and September 2024, having exercise prices ranging from $2.33 to $3.32 per share, at a reduced exercise price of $1.20 per share. The shares of common stock issuable upon exercise of the existing warrants are registered pursuant to an effective registration statements on Form S-1 (No. 333-292709) and Form S-3 (File No. 333-282739).
Roseland, NJ, Aug. 14, 2026 (GLOBE NEWSWIRE) -- --Gaxos.ai Inc. (“Gaxos” or the “Company”)(NASDAQ: GXAI), a company developing artificial intelligence applications across various high-growth sectors, today announced the entry into definitive agreements for the immediate exercise of certain outstanding warrants to purchase up to an aggregate of 3,007,654 shares originally issued in December 2024 and September 2024, having exercise prices ranging from $2.33 to $3.32 per share, at a reduced exercise price of $1.20 per share. The shares of common stock issuable upon exercise of the warrants are registered pursuant to an effective registration statements on Form S-1 (No. 333-292709) and Form S-3 (File No. 333-282739).
Revenue growth significantly outpaces advertising expense growth as revenue generated per advertising dollar improves Roseland, NJ, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company")(NASDAQ: GXAI), a company developing artificial intelligence applications across various high-growth sectors, today reported financial and operating results for the three and six months ended June 30, 2026. Second-quarter consolidated revenue reached a record of $2.46 million, representing an increase of 35.8% from $1.81 million in the first quarter of 2026 and an increase of 1,337% from $0.17 million in second quarter of 2025.
Benchmark GXAI against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Gaxos.ai Inc. (GXAI)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $0.58 | $5.94M | -1.06 | 47901.74% | -201.79% | -26.57% | — | |
| $1.90 | $143.52K | -0.00 | -82.47% | -140.37% | — | — | |
| $2.86 | $1.37B | -3.48 | -19.32% | -65.2% | -12.34% | — | |
| $6.01 | $2.62B | -173.70 | 99.45% | -67.45% | -30.22% | — | |
| $0.34 | $7.38M | -1.12 | 0.61% | -19.34% | -40.41% | — | |
| $2.20 | $836.83M | -4.00 | 8.08% | -9.89% | — | — |
Gaxos.ai Inc. (GXAI) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
Gaxos.ai Inc. (GXAI) SEC filings — annual & quarterly reports (10-K, 10-Q)
Aug 14, 2026·SEC
Aug 12, 2026·SEC
Aug 11, 2026·SEC
Get notified when GXAI posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Gaxos.ai Inc. (GXAI) stock FAQ — growth, dividends, profitability & financials explained
Gaxos.ai Inc. (GXAI) reported $6.0M in revenue for fiscal year 2025.
Gaxos.ai Inc. (GXAI) grew revenue by 47901.7% over the past year. This is strong growth.
Gaxos.ai Inc. (GXAI) reported a net loss of $3.9M for fiscal year 2025.
Gaxos.ai Inc. (GXAI) has a return on equity (ROE) of -26.6%. Negative ROE indicates the company is unprofitable.
Gaxos.ai Inc. (GXAI) had negative free cash flow of $5.5M in fiscal year 2025, likely due to heavy capital investments.
